The cumulative number of COVID-19 cases in Spain amounted to nearly 14 million as of July 28, 2024. Since Spain confirmed its first case, the authorities have reported approximately 122,000 deaths as a result of complications stemming from the disease, most of them in Madrid. COVID-19: background information COVID-19 is a disease caused by a novel coronavirus that had not previously been identified in humans. The first case was detected in the Hubei province of China at the end of December 2019. Multiple cases have been reported each day. At the beginning of the pandemic, few was known regarding the virus. Though some aspects still remain unclear, more information has been collected since the outbreak started, allowing a better understanding of the disease and its prevention and treatment, including the production of new vaccines. Immunization in Spain As of May 24, 2023, around 87 percent of the population in Spain had received at least one dose of a vaccine against COVID-19. Moreover, approximately 86 percent were already fully vaccinated. As of August 5, 2022, the number of pre-ordered doses of COVID-19 vaccines in the country amounted to 283.3 million, more than half of which were produced by Pfizer/BioNTech. Find the most up-to-date information about the coronavirus pandemic in the world under Statista’s COVID-19 facts and figures site.
As of June 28, 2023, the Spanish region suffering the highest number of COVID-19 cases was Catalonia, with over 2.6 million patients. The impact in the community of Madrid and Andalusia was also significant, with more than two million and approximately 1.65 million confirmed cases of the disease, respectively.
The outbreak in Spain The first confirmed case of COVID-19 in Spain was documented in La Gomera, Canary Islands, at the end of January 2020. Since then, Spanish authorities have reported around 13.9 million cases and over 121,000 deaths as a result of complications stemming from the disease. Not only the highest number of cases, but also most deaths have been reported in Catalonia and the Community of Madrid.
COVID-19: background information COVID-19 is a disease caused by a novel coronavirus that had not previously been identified in humans. The first case was detected in the Hubei province of China at the end of December 2019. Since then, multiple cases have been reported each day. At the beginning of the pandemic, few was known regarding the virus. Though some aspects still remain unclear, more information has been collected since the outbreak started, allowing a better understanding of the disease and its prevention and treatment, including the production of new vaccines.
Find the most up-to-date information about the coronavirus pandemic in the world under Statista’s COVID-19 facts and figures site.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
WHO: COVID-2019: Number of Patients: Confirmed: To-Date: Spain data was reported at 13,980,340.000 Person in 24 Dec 2023. This stayed constant from the previous number of 13,980,340.000 Person for 23 Dec 2023. WHO: COVID-2019: Number of Patients: Confirmed: To-Date: Spain data is updated daily, averaging 6,496,827.000 Person from Jan 2020 (Median) to 24 Dec 2023, with 1444 observations. The data reached an all-time high of 13,980,340.000 Person in 24 Dec 2023 and a record low of 0.000 Person in 18 Jan 2020. WHO: COVID-2019: Number of Patients: Confirmed: To-Date: Spain data remains active status in CEIC and is reported by World Health Organization. The data is categorized under High Frequency Database’s Disease Outbreaks – Table WHO.D002: World Health Organization: Coronavirus Disease 2019 (COVID-2019): by Country and Region (Discontinued). Due to some inclusions and exclusions of cases that are not properly reflected in WHO report, which are the result of the retrospective adjustments of national authorities, some current day “To-date” figures will not tally to the sum of previous day “To-date” cases and current day new reported cases. Figures with excluded cases are relatively lower compared to the previous day.
The coronavirus that originated in the Chinese city of Wuhan and spread to all Spanish regions mostly affected those aged 70-79 years, according to the most recent data. Some 23 percent of people hospitalized due to coronavirus coronavirus in Spain were aged in that age range. About 21 percent of those that contracted the COVID-19 aged 90 or over died from the complications caused by this virus during the same period. As of April 29, the number of people affected by this coronavirus in Spain was over 212 thousand. Madrid, the Spanish capital and the region with the highest number of cases, had a transmission rate of 912 cases every 100 thousand people as of the same date.
COVID-19: background information COVID-19 is a novel coronavirus that had not previously been identified in humans. The first case was detected in the Hubei province of China at the end of December 2019. Thousands of new cases are being reported each day, and because the illness has only recently been detected, it is not known exactly how the virus is spreading from person to person. However, the outbreak of the SARS coronavirus, which began in 2002, is thought to have spread via cough and sneeze droplets.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Project Tycho datasets contain case counts for reported disease conditions for countries around the world. The Project Tycho data curation team extracts these case counts from various reputable sources, typically from national or international health authorities, such as the US Centers for Disease Control or the World Health Organization. These original data sources include both open- and restricted-access sources. For restricted-access sources, the Project Tycho team has obtained permission for redistribution from data contributors. All datasets contain case count data that are identical to counts published in the original source and no counts have been modified in any way by the Project Tycho team, except for aggregation of individual case count data into daily counts when that was the best data available for a disease and location. The Project Tycho team has pre-processed datasets by adding new variables, such as standard disease and location identifiers, that improve data interpretability. We also formatted the data into a standard data format. All geographic locations at the country and admin1 level have been represented at the same geographic level as in the data source, provided an ISO code or codes could be identified, unless the data source specifies that the location is listed at an inaccurate geographical level. For more information about decisions made by the curation team, recommended data processing steps, and the data sources used, please see the README that is included in the dataset download ZIP file.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Data on daily COVID-19 confirmed cases, hospitalised people (both in conventional and intensive care units), and deaths, for Andalucía region in southern Spain, at the scale of both provinces and municipalities. Data cover the period from the very start of the pandemic (26 February 2020) up to 4 April 2022. The data were captured daily by Francisco Rodríguez-Sánchez from the official website of Junta de Andalucía (wayback machine capture from 1 February 2022 here). Note the official data were often changed retrospectively by the government as numbers were revised continuously. The full history of changes of both datasets can be checked at this GitHub repository: https://github.com/Pakillo/COVID19-Andalucia. There you can also get the R code used to analyse those data, which were visualised in an online daily report here: https://pakillo.github.io/COVID19-Andalucia/evolucion-coronavirus-andalucia.html.
According to the latest reports, more people died in Spain than were being born, with figures reaching over 439,000 deaths versus 322,000 newborns. The number of deaths experienced an upward trend over the 11-year period, presumably due to Spain’s aging population and in more recent years, the spread of COVID-19. Circulatory system diseases and cancer ranked as the most common causes of death in SpainThe cause of death can vary significantly across the globe and depends highly on economic development, presence of a competent healthcare system and one’s choices in lifestyle. In Spain, diseases related to the circulatory system and certain infectious and parasitic diseases ranked as the main causes of death, amounting to nearly 50,000 cases in the 2022. The annual number of deaths as a result of a disease of the circulatory system maintained steadily over the most recent years, with the illness being more common among female than male individuals. Cancer numbers in SpainThe number of deaths as a result of a cancer grew steadily in Spain for both women and men, although the disease seems to affect more male individuals than female, with about 68,000 cases occurring in men and 45,000 in women according to the most recent data. Furthermore, of the total 276,260 new cases of cancer in Spain in 2023, roughly 158,500 were diagnosed among male individuals.
https://administraciodigital.gencat.cat/ca/dades/dades-obertes/informacio-practica/llicencies/https://administraciodigital.gencat.cat/ca/dades/dades-obertes/informacio-practica/llicencies/
Actualització de les dades aturada per la font de dades el 22/09/2020.
Dades diàries de la incidència de la COVID-19 a Catalunya elaborades per l’IDESCAT a partir de dades del Departament de Salut i del Ministeri de Sanitat. La sèrie s'inicia el 24 de febrer de 2020 i s'actualitza cada dia. Es proporcionen les xifres diàries de nous casos confirmats, defuncions i altes hospitalàries, així com els totals acumulats.
Notes: - Les dades poden presentar oscil·lacions o incoherències derivades dels processos de depuració. - Les dades del període del 15 a 23 d’abril de 2020 (que provenien del Departament de Salut) s’han revisat, a conseqüència de la substitució de la informació del Departament de Salut per la del Ministeri de Sanitat. - El 16 d’abril disminueix la xifra total de defuncions i altes hospitalàries, per una revisió de dades del Ministeri de Sanitat. - El Ministeri de Sanitat informa que en l’augment del total de casos confirmats els dies 10, 11, 15 i 16 de maig s’han considerat, a més dels casos nous, alguns casos antics. - El 14 i el 18 de maig disminueix la xifra total de casos confirmats, per una revisió de dades del Ministeri de Sanitat. - Les dades de defuncions fins al 23 de maig de 2020 fan referència a defuncions diàries i a partir del 24 de maig de 2020 fan referència a defuncions dels darrers 7 dies.
[ES] Datos diarios de la incidencia de la COVID-19 en Cataluña elaborados por el IDESCAT a partir de datos del Departamento de Salud y del Ministerio de Sanidad La serie se inicia el 24 de febrero de 2020 y se actualiza cada día. Se proporcionan las cifras diarias de nuevos casos confirmados, defunciones y altas hospitalarias, así como los totales acumulados.
Notas: - Los datos pueden presentar oscilaciones o incoherencias derivadas de los procesos de depuración. - Los datos del período del 15 al 23 de abril de 2020 (que provenían del Departamento de Salud) se han revisado, a consecuencia de la sustitución de la información del Departamento de Salud por la del Ministerio de Sanidad. - El 16 de abril disminuye la cifra total de defunciones y altas hospitalarias, por una revisión de datos del Ministerio de Sanidad. - El Ministerio de Sanidad informa de que en el aumento del total de casos confirmados los días 10, 11, 15 y 16 de mayo se han considerado, además de los casos nuevos, algunos casos antiguos. - El 14 y el 18 de mayo disminuye la cifra total de casos confirmados, por una revisión de datos del Ministerio de Sanidad. - Los datos de defunciones hasta el 23 de mayo de 2020 hacen referencia a defunciones diarias y a partir del 24 de mayo de 2020 hacen referencia a defunciones de los últimos 7 días.
[EN] Daily data of the COVID-19 incidence in Catalonia elaborated by IDESCAT using data from the Department of Health and Spanish Ministry of Health. Series starts on the 24th February 2020 and is updated every day. The daily numbers of new confirmed cases, demises and hospital discharges are provided, as well as the accumulated totals.
Notes: - the data may include fluctuations or inconsistencies derived from editing processes. - The data for the period from 15 to 23 April, 2020 (which came from the Department of Health) have been revised, as a result of replacing the information of the Catalan Ministry of Health by that of the Spanish Ministry of Health. - On April 16, the total number of deaths and hospital discharges decreased, due to a review of data from the Ministry of Health. - The Ministry of Health reports that in the increase in total confirmed cases on 10, 11, 15 and 16 May, some old cases were included in addition to new cases. - On May 14 and May 18, the total of confirmed cases decreased, due to a review of data from the Ministry of Health. - Death data until May 23, 2020 refers to daily deaths and after May 24, 2020 refers to deaths in the last 7 days.
https://www.globaldata.com/privacy-policy/https://www.globaldata.com/privacy-policy/
First reported in Wuhan, China, in December 2019, now more than 846,200 confirmed cases of COVID-19 are spread across 187 countries worldwide. The US and several countries in Europe such as Italy, Spain, and Belgium have continued to see a decrease in daily cases. Russia, Brazil, and Latin American countries are seeing increasing trends. India has also seen an increase in the number of new cases reported despite strict distancing measures taken early on.
Special populations analysis covered in the report include the following:
COVID-19 in children may result in systemic multisystem syndrome with severe outcomes.
Childhood routine vaccination rates drop during pandemic.
COVID-19’s impact in pregnant women unclear, though most cases are asymptomatic.
The COVID-19 pandemic could cause an increase in the prevalence of post-traumatic stress disorder (PTSD).
Complications of opioid addiction will be challenging for the management of disease during the COVID-19 pandemic. Read More
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
WHO: EVD: Total Cases: Spain data was reported at 1.000 Unit in 23 Nov 2014. This stayed constant from the previous number of 1.000 Unit for 18 Nov 2014. WHO: EVD: Total Cases: Spain data is updated daily, averaging 1.000 Unit from Oct 2014 (Median) to 23 Nov 2014, with 14 observations. The data reached an all-time high of 1.000 Unit in 23 Nov 2014 and a record low of 1.000 Unit in 23 Nov 2014. WHO: EVD: Total Cases: Spain data remains active status in CEIC and is reported by World Health Organization. The data is categorized under High Frequency Database’s Disease Outbreaks – Table WHO.D001: World Health Organization: Ebola Virus Disease (EVD): By Countries.
January was the month that featured the highest number of deaths in 2024, with more than 48,760 registered deceases. In contrast, September had the lowest number, at 31,632 deaths. The latest figures reveal that more people died in Spain than were being born in 2024, with figures reaching over 439,146 deaths versus 322,00 newborns. The number of deaths experienced an upward trend over the past years, presumably due to Spain’s aging population. Circulatory system diseases and cancer ranked as the most common causes of death in Spain The cause of death can vary significantly across the globe and depends highly on economic development, the presence of a competent healthcare system and one’s choices in lifestyle. In Spain, diseases related to the circulatory system, certain infectious and parasitic diseases, and neoplasms (cancer) ranked as the main causes of death, all three with over 275,000 cases in 2022. The annual number of deaths as a result of a disease of the circulatory system maintained steadily over the most recent years, with the illness being more common among female than male individuals. Cancer numbers in Spain The number of deaths as a result of a cancer grew steadily in Spain for both women and men, although the disease seems to affect more male individuals than female, with 67,911 cases occurring in men and 46,917 in women according to the latest data. Furthermore, of the total 276,260 new cases of cancer in Spain in 2023, nearly 158,500 were diagnosed among male individuals.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
ECDC: COVID-2019: Number of Deaths: Spain data was reported at 0.000 Person in 13 Dec 2020. This stayed constant from the previous number of 0.000 Person for 12 Dec 2020. ECDC: COVID-2019: Number of Deaths: Spain data is updated daily, averaging 5.000 Person from Dec 2019 (Median) to 13 Dec 2020, with 349 observations. The data reached an all-time high of 1,623.000 Person in 04 Nov 2020 and a record low of -1,918.000 Person in 25 May 2020. ECDC: COVID-2019: Number of Deaths: Spain data remains active status in CEIC and is reported by European Centre for Disease Prevention and Control. The data is categorized under High Frequency Database’s Disease Outbreaks – Table ECDC.D001: Coronavirus Disease 2019 (COVID-2019): Cases and Deaths: by EU Member States (Discontinued).
The coronavirus that originated in the Chinese city of Wuhan and spread to all Spanish regions had a higher mortality rate among those aged over 80 years old, according to the most recent data. In this age group, 21 percent of those that contracted the COVID-19 died from the complications caused by this virus. As of November 24, the disease mostly affected those aged 70-79 yearswith about 23 percent of coronavirus hospitalizations found in that age range. As of November 24, the number of people affected by this coronavirus in Spain was about over 343 thousand. Madrid, the Spanish capital and the region with the highest number of cases, had a transmission rate of 5,129 cases every 100 thousand people as of the same date.
Spain: one of the epicentres of the outbreak Since Spain confirmed its first case, the authorities have confirmed 28.7 deaths as a result of complications from coronavirus, most of them in the Community of Madrid. As of the same date, the number of recoveries Spain registered was significantly higher than that of deaths, with over 150 thousand patients that were able to regain their health. In Spain, the first confirmed case was a German tourist spending some days in La Gomera, Canary Islands, at the end of January 2020.
COVID-19: background information COVID-19 is a novel coronavirus that had not previously been identified in humans. The first case was detected in the Hubei province of China at the end of December 2019. Thousands of new cases are being reported each day, and because the illness has only recently been detected, it is not known exactly how the virus is spreading from person to person. However, the outbreak of the SARS coronavirus, which began in 2002, is thought to have spread via cough and sneeze droplets.
Find the most up-to-date information about the coronavirus pandemic in the world under Statista’s COVID-19 facts and figures site.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Spain MSCBS: COVID-19: Number of Cases: To-Date: Confirmed (CC) data was reported at 236,199.000 Person in 26 Apr 2020. This records an increase from the previous number of 226,629.000 Person for 25 Apr 2020. Spain MSCBS: COVID-19: Number of Cases: To-Date: Confirmed (CC) data is updated daily, averaging 102,136.000 Person from Feb 2020 (Median) to 26 Apr 2020, with 53 observations. The data reached an all-time high of 236,199.000 Person in 26 Apr 2020 and a record low of 32.000 Person in 28 Feb 2020. Spain MSCBS: COVID-19: Number of Cases: To-Date: Confirmed (CC) data remains active status in CEIC and is reported by Ministry of Health, Consumer Affairs and Social Welfare. The data is categorized under High Frequency Database’s Disease Outbreaks – Table ES.D001: Ministry of Health, Consumer Affairs and Social Welfare: Coronavirus Disease 2019 (COVID-2019) (Discontinued). Ministry of Health, Consumer Affairs and Social Welfare of Spain has changed its criteria for reporting the total number of confirmed COVID-19 cases. Until 26 April 2020 the total number of cases and its derivatives by areas include those with positive polymerase chain reaction (PCR) test results and with positive tests for antibodies (TestAc+). As of this date the replacement series and its derivatives by areas include only cases confirmed by PCR test results. 2. Replacement series ID: 449481357
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Spain MSCBS: COVID-19: Number of Cases: To Date: CC: Castile and Leon data was reported at 19,028.000 Person in 26 Apr 2020. This records an increase from the previous number of 18,684.000 Person for 25 Apr 2020. Spain MSCBS: COVID-19: Number of Cases: To Date: CC: Castile and Leon data is updated daily, averaging 9,348.500 Person from Mar 2020 (Median) to 26 Apr 2020, with 42 observations. The data reached an all-time high of 19,028.000 Person in 26 Apr 2020 and a record low of 431.000 Person in 16 Mar 2020. Spain MSCBS: COVID-19: Number of Cases: To Date: CC: Castile and Leon data remains active status in CEIC and is reported by Ministry of Health, Consumer Affairs and Social Welfare. The data is categorized under High Frequency Database’s Disease Outbreaks – Table ES.D001: Ministry of Health, Consumer Affairs and Social Welfare: Coronavirus Disease 2019 (COVID-2019) (Discontinued). Ministry of Health, Consumer Affairs and Social Welfare of Spain has changed its criteria for reporting the total number of confirmed COVID-19 cases. Until 26 April 2020 the total number of cases and its derivatives by areas include those with positive polymerase chain reaction (PCR) test results and with positive tests for antibodies (TestAc+). As of this date the replacement series and its derivatives by areas include only cases confirmed by PCR test results. 2. Replacement series ID: 449481437
The number of COVID-19 cases in Spain amounted to around 13.9 million as of June 28, 2023. As of that date, the Spanish authorities had confirmed approximately 121,760 deaths as a result of complications stemming from the disease, most of them reported in Madrid and Catalonia, with 21,361 deaths and 21,241 casualties related to COVID-19, respectively.
Find the most up-to-date information about the coronavirus pandemic in the world under Statista’s COVID-19 facts and figures site.
The number of cases of the coronavirus disease that originated in the Chinese city of Wuhan (COVID-19) in Spain amounted to 221 thousand as of May 7, 2020. Since Spain confirmed its first case, the authorities have confirmed 25.4 thousand deaths as a result of complications from coronavirus. As of the same date, the number of recoveries Spain registered was significantly higher than that of deaths, with over 128 thousand patients that were able to regain their health. The virus spread to all Spanish regions, with the Community of Madrid suffering the highest number of cases with over 64 thousand people.
The impact of the outbreak of this disease was such that the global stock markets were affected. The Spanish IBEX-35 was no exception to that, decreasing by 2500 stock market points during the first days of March.
COVID-19: background information COVID-19 is a novel coronavirus that had not previously been identified in humans. The first case was detected in the Hubei province of China at the end of December 2019. Thousands of new cases are being reported each day, and because the illness has only recently been detected, it is not known exactly how the virus is spreading from person to person. However, the outbreak of the SARS coronavirus, which began in 2002, is thought to have spread via cough and sneeze droplets.
In order to develop various methods of comparable data collection on health and health system responsiveness WHO started a scientific survey study in 2000-2001. This study has used a common survey instrument in nationally representative populations with modular structure for assessing health of indviduals in various domains, health system responsiveness, household health care expenditures, and additional modules in other areas such as adult mortality and health state valuations.
The health module of the survey instrument was based on selected domains of the International Classification of Functioning, Disability and Health (ICF) and was developed after a rigorous scientific review of various existing assessment instruments. The responsiveness module has been the result of ongoing work over the last 2 years that has involved international consultations with experts and key informants and has been informed by the scientific literature and pilot studies.
Questions on household expenditure and proportionate expenditure on health have been borrowed from existing surveys. The survey instrument has been developed in multiple languages using cognitive interviews and cultural applicability tests, stringent psychometric tests for reliability (i.e. test-retest reliability to demonstrate the stability of application) and most importantly, utilizing novel psychometric techniques for cross-population comparability.
The study was carried out in 61 countries completing 71 surveys because two different modes were intentionally used for comparison purposes in 10 countries. Surveys were conducted in different modes of in- person household 90 minute interviews in 14 countries; brief face-to-face interviews in 27 countries and computerized telephone interviews in 2 countries; and postal surveys in 28 countries. All samples were selected from nationally representative sampling frames with a known probability so as to make estimates based on general population parameters.
The survey study tested novel techniques to control the reporting bias between different groups of people in different cultures or demographic groups ( i.e. differential item functioning) so as to produce comparable estimates across cultures and groups. To achieve comparability, the selfreports of individuals of their own health were calibrated against well-known performance tests (i.e. self-report vision was measured against standard Snellen's visual acuity test) or against short descriptions in vignettes that marked known anchor points of difficulty (e.g. people with different levels of mobility such as a paraplegic person or an athlete who runs 4 km each day) so as to adjust the responses for comparability . The same method was also used for self-reports of individuals assessing responsiveness of their health systems where vignettes on different responsiveness domains describing different levels of responsiveness were used to calibrate the individual responses.
This data are useful in their own right to standardize indicators for different domains of health (such as cognition, mobility, self care, affect, usual activities, pain, social participation, etc.) but also provide a better measurement basis for assessing health of the populations in a comparable manner. The data from the surveys can be fed into composite measures such as "Healthy Life Expectancy" and improve the empirical data input for health information systems in different regions of the world. Data from the surveys were also useful to improve the measurement of the responsiveness of different health systems to the legitimate expectations of the population.
Sample survey data [ssd]
The metropolitan, urban and rural population and all iadministrative regional unitsi as defined in Official Europe Union Statistics (NUTS 2) covered proportionately the respective population aged 18 and above. The country was divided into an appropriate number of areas, grouping NUTS regions at whatever level appropriately. The NUTS covered in Spain were the following; Andalucia, AragUn, Asturias, Baleares, Canarias, Cantabria, Castilla-La Mancha, Castilla-LeUn, CataluOa, Extremadura, Galicia, La Rioja, Madrid, Murcia, Navarra, PaIs Vasco, PaIs Valenciano. The basic sample design was a multi-stage, random probability sample. 100 sampling points were drawn with probability proportional to population size, for a total coverage of the country. The sampling points were drawn after stratification by NUTS 2 region and by degree of urbanisation. They represented the whole territory of the country surveyed and are selected proportionally to the distribution of the population in terms of metropolitan, urban and rural areas.
In each of the selected sampling points, one address was drawn at random. This starting address forms the first address of a cluster of a maximum of 20 addresses. The remainder of the cluster was selected as every Nth address by standard random route procedure from the initial address. In theory, there is no maximum number of addresses issued per country.
Procedures for random household selection and random respondent selection are independent of the intervieweris decision and controlled by the institute responsible. They should be as identical as possible from to country, full functional equivalence being a must.
At every address up to 4 recalls were made to attempt to achieve an interview with the selected respondent. There was only one interview per household. The final sample size is 1,000 completed interviews.
Face-to-face [f2f]
Data Coding At each site the data was coded by investigators to indicate the respondent status and the selection of the modules for each respondent within the survey design. After the interview was edited by the supervisor and considered adequate it was entered locally.
Data Entry Program A data entry program was developed in WHO specifically for the survey study and provided to the sites. It was developed using a database program called the I-Shell (short for Interview Shell), a tool designed for easy development of computerized questionnaires and data entry (34). This program allows for easy data cleaning and processing.
The data entry program checked for inconsistencies and validated the entries in each field by checking for valid response categories and range checks. For example, the program didn’t accept an age greater than 120. For almost all of the variables there existed a range or a list of possible values that the program checked for.
In addition, the data was entered twice to capture other data entry errors. The data entry program was able to warn the user whenever a value that did not match the first entry was entered at the second data entry. In this case the program asked the user to resolve the conflict by choosing either the 1st or the 2nd data entry value to be able to continue. After the second data entry was completed successfully, the data entry program placed a mark in the database in order to enable the checking of whether this process had been completed for each and every case.
Data Transfer The data entry program was capable of exporting the data that was entered into one compressed database file which could be easily sent to WHO using email attachments or a file transfer program onto a secure server no matter how many cases were in the file. The sites were allowed the use of as many computers and as many data entry personnel as they wanted. Each computer used for this purpose produced one file and they were merged once they were delivered to WHO with the help of other programs that were built for automating the process. The sites sent the data periodically as they collected it enabling the checking procedures and preliminary analyses in the early stages of the data collection.
Data quality checks Once the data was received it was analyzed for missing information, invalid responses and representativeness. Inconsistencies were also noted and reported back to sites.
Data Cleaning and Feedback After receipt of cleaned data from sites, another program was run to check for missing information, incorrect information (e.g. wrong use of center codes), duplicated data, etc. The output of this program was fed back to sites regularly. Mainly, this consisted of cases with duplicate IDs, duplicate cases (where the data for two respondents with different IDs were identical), wrong country codes, missing age, sex, education and some other important variables.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Spain ES: Time Required to Enforce a Contract data was reported at 510.000 Day in 2017. This stayed constant from the previous number of 510.000 Day for 2016. Spain ES: Time Required to Enforce a Contract data is updated yearly, averaging 515.000 Day from Dec 2003 (Median) to 2017, with 15 observations. The data reached an all-time high of 515.000 Day in 2011 and a record low of 510.000 Day in 2017. Spain ES: Time Required to Enforce a Contract data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Spain – Table ES.World Bank: Company Statistics. Time required to enforce a contract is the number of calendar days from the filing of the lawsuit in court until the final determination and, in appropriate cases, payment.; ; World Bank, Doing Business project (http://www.doingbusiness.org/).; Unweighted average; Data are presented for the survey year instead of publication year.
According to the latest reports, Extremadura was the Spanish autonomous community that featured the highest consumption of tobacco, as a quarter of its population reported to be daily smokers in 2022. Most of the Spanish regions, however, registered a prevalence of tobacco use of over 17 percent with the exception of the communities of Melilla and the Basque Country. Andalusia ranked, on the other hand, as the Spanish autonomous community with the highest number of smokers, reaching over 1.4 million daily smokers in 2022.
The demographics of tobacco use in Spain In Spain, an average of 22 percent of the population reported to smoke in 2022, with 20 percent of them being daily smokers. Former smokers accounted for 22 percent of the population, whereas more than half of Spaniards represented the non-smoking community of the Mediterranean country. Approximately 7.9 million people were daily smokers in Spain as of 2022, of which around 3.3 million were women and about 4.5 million were men.
Smoking and cancer It is very clear these days that there is a direct connection between smoking and cancer. Lung cancer is the fourth most commonly diagnosed type of cancer in Spain with almost 30 thousand new cases estimated for 2021, according to the most recent studies. The number of deaths as a result of lung cancer has maintained over 20 thousand cases in the last few years. Lung cancer deaths in men outnumbered by far the deaths in women, with over 16.5 thousand cases among the male population in comparison with 5.2 thousand cases among their female co-nationals in 2020. Also that year, deaths as a consequence of lung tumors were most common among the population aged 65 to 74.
The cumulative number of COVID-19 cases in Spain amounted to nearly 14 million as of July 28, 2024. Since Spain confirmed its first case, the authorities have reported approximately 122,000 deaths as a result of complications stemming from the disease, most of them in Madrid. COVID-19: background information COVID-19 is a disease caused by a novel coronavirus that had not previously been identified in humans. The first case was detected in the Hubei province of China at the end of December 2019. Multiple cases have been reported each day. At the beginning of the pandemic, few was known regarding the virus. Though some aspects still remain unclear, more information has been collected since the outbreak started, allowing a better understanding of the disease and its prevention and treatment, including the production of new vaccines. Immunization in Spain As of May 24, 2023, around 87 percent of the population in Spain had received at least one dose of a vaccine against COVID-19. Moreover, approximately 86 percent were already fully vaccinated. As of August 5, 2022, the number of pre-ordered doses of COVID-19 vaccines in the country amounted to 283.3 million, more than half of which were produced by Pfizer/BioNTech. Find the most up-to-date information about the coronavirus pandemic in the world under Statista’s COVID-19 facts and figures site.